Innovation Medical Management Co .,Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Established: 2003-09-30

Employees: 36

Market Cap: -

Website: http://www.chxyl.com

Introduction: The company was founded in April 1997, completed its initial public offering of shares and listed on September 25, 2007. As the reform of the medical service industry continues to deepen, excellent private hospitals will achieve rapid development, and the profitability of target hospitals will continue to increase steadily in subsequent years. After the transaction is completed, the injection of high-quality assets will greatly enhance the profitability of listed companies, thereby maximizing shareholder value. The company is a listed company whose main business is providing medical services. Corporate honors: It won the third prize for the application of new medical and health technology at the provincial level in 2018, etc.

Clinical Trials

Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity

Phase 4

Conditions: Dry Eye

Interventions: Drug: FreshKote
Drug: Systane

First Posted Date: 2011-06-30

Last Posted Date: 2012-06-14

Lead Sponsor: Innovative Medical

Target Recruit Count: 40

Registration Number: NCT01386073

Locations: 🇺🇸
Jackson Eye, S.C, Lake Villa, Illinois, United States
🇺🇸
Pepose Vision Institute, Chesterfield, Missouri, United States

Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract Surgery

Phase 4

Completed

Conditions: Cataracts

Interventions: Procedure: Femtosecond Laser

First Posted Date: 2011-06-28

Last Posted Date: 2012-02-17

Lead Sponsor: Innovative Medical

Target Recruit Count: 29

Registration Number: NCT01383057

Locations: 🇺🇸
Loden Vision Centers, Goodlettsville, Tennessee, United States

Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract Surgery

Phase 4

Conditions: Cataracts

Interventions: Device: Hoya AF-1 IOL
Device: Revital vision

First Posted Date: 2011-06-27

Last Posted Date: 2011-10-06

Lead Sponsor: Innovative Medical

Target Recruit Count: 20

Registration Number: NCT01382641

Locations: 🇺🇸
McDonald Eye Associates, PA, Fayetteville, Arkansas, United States

Laser Cataract Surgery With the Femtosecond Laser Technology

Phase 4

Completed

Conditions: Cataracts

Interventions: Procedure: Femtosecond Laser

First Posted Date: 2011-06-27

Last Posted Date: 2011-10-06

Lead Sponsor: Innovative Medical

Target Recruit Count: 10

Registration Number: NCT01382823

Locations: 🇺🇸
Loden Vision Centers, Goodlettsville, Tennessee, United States

Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms

Phase 4

Conditions: Dry Eye Syndromes

Interventions: Drug: Altaire Gel forming solution
Drug: Refresh Tears

First Posted Date: 2011-06-27

Last Posted Date: 2012-06-14

Lead Sponsor: Innovative Medical

Target Recruit Count: 100

Registration Number: NCT01382810

Locations: 🇺🇸
Koch Eye Associates, Warwick, Rhode Island, United States
🇺🇸
Jackson Eye, SC, Lake Villa, Illinois, United States

Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions

Phase 4

Completed

Conditions: Cataracts

Interventions: Drug: Saline
Drug: Viscoat

First Posted Date: 2011-02-18

Last Posted Date: 2012-01-18

Lead Sponsor: Innovative Medical

Target Recruit Count: 50

Registration Number: NCT01298973

Locations: 🇺🇸
Eye Physicians of Central Florida, Maitland, Florida, United States
🇺🇸
Florida Eye Microsurgical Institute, Boynton Beach, Florida, United States

Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial

Phase 4

Completed

Conditions: Cataracts
Astigmatism

Interventions: Device: Abbott WHITESTAR Signature System with Ellips Transversal Ultrasound
Device: Alcon Infiniti wiht the OZIL Torsional Handpiece

First Posted Date: 2011-01-19

Last Posted Date: 2012-01-18

Lead Sponsor: Innovative Medical

Target Recruit Count: 25

Registration Number: NCT01279031

Locations: 🇺🇸
Kerry Assil, Beverly Hills, California, United States

Evaluation of Visual Outcomes of Monovision Patients Bilaterally Implanted With Nanoflex Intraocular Lenses

Phase 4

Conditions: Patients Who Have Bilateral NanoFlex Implantation at Least 3 Months Previously

Interventions: Device: Nanoflex IOL

First Posted Date: 2011-01-19

Last Posted Date: 2011-02-17

Lead Sponsor: Innovative Medical

Target Recruit Count: 100

Registration Number: NCT01279122

Locations: 🇺🇸
Kenneth Lipstock, Richmond, Virginia, United States

AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL

Phase 4

Conditions: Cataract

Interventions: Device: Tecnis MF
Device: ReSTOR

First Posted Date: 2011-01-17

Last Posted Date: 2012-06-14

Lead Sponsor: Innovative Medical

Target Recruit Count: 60

Registration Number: NCT01278420

Locations: 🇺🇸
Sansum- Santa Barbara medical foundation Clinic, Santa Barbara, California, United States
🇺🇸
Katzen Eye Care & Laser Center, Boynton Beach, Florida, United States
🇺🇸
The Center for Excellence in Eye Care, Miami, Florida, United States

and more 3 locations

Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

Phase 4

Conditions: Pseudophakia
Cataract Surgery

Interventions: Drug: Pred Forte
Drug: Lotemax

First Posted Date: 2010-09-02

Last Posted Date: 2012-06-14

Lead Sponsor: Innovative Medical

Target Recruit Count: 100

Registration Number: NCT01193504

Locations: 🇺🇸
The Center For Excellence in Eye care, Miami, Florida, United States
🇺🇸
Harvard Eye Associates, Laguna Hills, California, United States
🇺🇸
Ophthalmic Consultants of Boston, Waltham, Massachusetts, United States

Home Terms & Conditions Privacy Policy